Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Australia may soon subsidize weight loss drugs like Ozempic and Wegovy, expanding access beyond diabetes patients.

flag Australia may soon offer subsidized access to weight loss drugs like Ozempic and Wegovy through its Pharmaceutical Benefits Scheme, potentially lowering costs for users. flag Health Minister Mark Butler confirmed the government is evaluating a bid by Novo Nordisk to include Wegovy, with expert advice expected early in 2026. flag Currently, these GLP-1 drugs are only subsidized for type 2 diabetes, leaving around half a million Australians paying privately between $200 and $600 monthly. flag Concerns have been raised by the Therapeutic Goods Administration about possible links to suicidal thoughts and reduced effectiveness of oral contraceptives with some GLP-1 drugs. flag The government aims to balance broader access with safety and equity.

14 Articles